Vertex (VRTX) shares have been halted as an FDA advisory panel will review its telaprevir NDA today
Tweet
Share
E-mailGet Alerts VRTX Hot Sheet
Join SI Premium – FREE
Vertex (Nasdaq: VRTX) shares have been halted as an FDA advisory panel will review its telaprevir NDA today
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Vortex Energy Announces Final Ambient Noise Tomography Results for the Robinsons River Salt Project
- FDA clears path for Protagenic's PT00114 anxiety drug IND submission
- AC Immune reports early Phase 1 data for NLRP3 inhibitor ACI-19764
Create E-mail Alert Related Categories
FDA, Trading HaltsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
